• No results found

Quality of prescribing in chronic kidney disease and type 2 diabetes

N/A
N/A
Protected

Academic year: 2021

Share "Quality of prescribing in chronic kidney disease and type 2 diabetes"

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Quality of prescribing in chronic kidney disease and type 2 diabetes Smits, Kirsten Petronella Juliana

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Smits, K. P. J. (2018). Quality of prescribing in chronic kidney disease and type 2 diabetes. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

SHARE publications

267

S

Research Institute SHARE

This thesis is published within the Research Institute SHARE (Science in Healthy Ageing and healthcaRE) of the University Medical Center Groningen / University of Groningen.

Further information regarding the institute and its research can be obtained from our internetsite: http://www.share.umcg.nl/.

More recent theses can be found in the list below.

((co-) supervisors are between brackets) 2017

Magnée T

Mental health care in general practice in the context of a system reform (prof PFM Verhaak, prof FG Schellevis, prof DH de Bakker, dr DP de Beurs)

Zon SKR van

Socioeconomic inequalities in work and health (prof SA Reijneveld, prof U Bültmann)

Most PJ van der

Development of bioinformatic tools and application of novel statistical methods in genome-wide analysis

(prof H Snieder, Prof P van der Harst, dr IM Nolte)

Fleurke-Rozema H Impact of the 20-week scan

(prof CM Bilardo, prof E Pajkrt, dr RJM Snijders)

Schripsema NR

Medical students selection; effects of different admissions processes (prof J Cohen-Schotanus, prof JCC Borleffs, dr AM van Trigt)

Ven HA van de

Shift your work; towards sustainable employability by implementing new shift systems

(prof JJL van der Klink, prof MP de Looze, prof U Bültmann, prof S Brouwer)

(3)

Hoekstra F

ReSpAct: Rehabilitation, sports and active lifestyle

(prof LHV van der Woude, prof CP van der Schans, dr R Dekker, dr FJ Hettinga)

De Carvalho Honorato T

Diminished ovarian reserve and adverse reproductive outcomes (prof A Hoek, prof HM Boezen, dr H Groen, dr ML Haadsma)

Olthof M

Patient characteristics related to health care consumption; towards a differenti- ated capitation model

(prof SK Bulstra, prof MY Berger, dr I van den Akker-Scheek, dr M Stevens)

Bessem B

The young athlete’s heart; an electrocardiographic challenge (prof J Zwerver, prof MP van den Berg, dr W Nieuwland)

Husarova D

Barriers to active participation of school-aged children (prof SA Reijneveld, prof A Madarasova-Geckova, dr JP van Dijk)

Schenk HM

Affect and physical health; studies on the link between affect and physiologiocal processes

(prof JGM Rosmalen, prof P de Jonge, prof JPJ Slaets)

Wilk AD van der

Patient centered development and clinical evaluation of an ankle foot orthosis (prof GJ Verkerke, prof K Postema, dr JM Hijmans)

Koorevaar R

Psychological symptoms and clinical outcome after shoulder surgery (prof SK Bulstra)

Beijersbergen CMI

Effects of lower extremity power training on gait biomechanics in old adults; the Potsdam Gait Study (POGS)

(prof T Hortobagyi, prof P DeVita, prof U Granacher)

(4)

SHARE publications

269

S

Islam Md A

Statistical approaches to explore clinical heterogeneity in psychosis (prof ER van den Heuvel, dr R Bruggeman, dr BZ Alizadeh)

Dallinga JM

Injury prevention in team sport athletes (prof KAPM Lemmink, dr A Benjaminse)

For more 2017 and earlier theses visit our website.

(5)

Kirsten P.J. Smits Quality of prescribing in chronic kidney disease and type 2 diabetes

Quality of prescribing in chronic kidney disease and type 2 diabetes

Kirsten P.J. Smits

voor het bijwonen van de openbare verdediging van mijn proefschrift

Quality of prescribing in chronic kidney disease and type 2 diabetes

op woensdag 21 februari 2018 om 16.15 uur in de aula van het Academiegebouw van de Rijksuniversiteit Groningen, Broerstraat 5 te Groningen.

Aansluitend op de promotie is er een receptie in het Academiegebouw.

Kirsten Smits

De Vaandeldrager 4 6921TK Duiven 06-22210183 k.p.j.smits@umcg.nl Paranimfen

Sophie van den Belt s.m.van.den.belt@umcg.nl Sieta de Vries

s.t.de.vries@umcg.nl

Referenties

GERELATEERDE DOCUMENTEN

All eight clinical action indicators on start and intensifica- tion of glucose lowering drugs, statins, antihypertensives, and RAAS inhibitors were predictive of

Therefore, the primary aim of this study in T2D patients was to assess the re- lationship of (I) guideline-adherent prescribing of renin-angiotensin-aldosterone system

The newly developed PQIs, including the clinical action indicators, have been developed and defined in such a way that they can be implemented in quality improvement initiatives

The selected PQIs were three indicators on current prescribing of statins and RAAS inhibitors when recommended and four PQIs on potential inappropriate

Tijdens de ontwikkeling zijn verscheidene indicatoren verworpen, zoals de volume-indicatoren over het gebruik van bloedglucose-ver- lagende middelen en de

· The percentage of patients with CrCl <60 ml/min that is non-adherent to the diabetes treatment since the patient received more than 120% or less than 80% of the

10 percentage points for the medication need and medication choice indicators and at 5 percentage points for safety indicators with outcome >5% or 1 percent- age point for

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded